Moomoo AI 已提取核心訊息
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 20,054 shares of Class A Common Stock on March 19, 2024. The shares were sold at a price of $10.792 per share, resulting in a total transaction value of approximately $216,422.77. Following the sale, Borgeson's direct holdings in the company amount to 7,252,755 shares. The transaction was executed in the open market and is part of the normal course of trading activities.
Blake Borgeson, a reporting person associated with Recursion Pharmaceuticals, Inc. [RXRX], completed a sale of 20,054 shares of Class A Common Stock on March 19, 2024. The shares were sold at a price of $10.792 per share, resulting in a total transaction value of approximately $216,422.77. Following the sale, Borgeson's direct holdings in the company amount to 7,252,755 shares. The transaction was executed in the open market and is part of the normal course of trading activities.
與Recursion Pharmicals, Inc. [RXRX] 相關的申報人布萊克·博格森於2024年3月19日完成了20,054股A類普通股的出售。這些股票以每股10.792美元的價格出售，總交易價值約爲216,422.77美元。出售後，博格森在該公司的直接持股量爲7,252,755股。該交易是在公開市場上執行的，是正常交易活動的一部分。
與Recursion Pharmicals, Inc. [RXRX] 相關的申報人布萊克·博格森於2024年3月19日完成了20,054股A類普通股的出售。這些股票以每股10.792美元的價格出售，總交易價值約爲216,422.77美元。出售後，博格森在該公司的直接持股量爲7,252,755股。該交易是在公開市場上執行的，是正常交易活動的一部分。
有用
沒用